The design of novel muscarinic partial agonists that have functional selectivity in pharmacological preparations in vitro and reduced side-effect profile in vivo
- 1 January 1993
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 52 (5-6) , 489-495
- https://doi.org/10.1016/0024-3205(93)90306-n
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Synthesis and muscarinic activity of quinuclidinyl- and (1-azanorbornyl)pyrazine derivativesJournal of Medicinal Chemistry, 1992
- A novel series of non‐quaternary oxadiazoles acting as full agonists at muscarinic receptorsBritish Journal of Pharmacology, 1990
- In vivo characterisation of novel efficacious muscarinic receptor agonistsEuropean Journal of Pharmacology, 1990
- Synthesis and biological activity of 1,2,4-oxadiazole derivatives: highly potent and efficacious agonists for cortical muscarinic receptorsJournal of Medicinal Chemistry, 1990
- Direct measurement of muscarinic agents in the central nervous system of mice using ex vivo bindingEuropean Journal of Pharmacology, 1989
- Predicting the biologically conformations of short polypeptidesTrends in Pharmacological Sciences, 1989
- Localization of a family of muscarinic receptor mRNAs in rat brainJournal of Neuroscience, 1988
- Relative affinities of drugs acting at cholinoceptors in displacing agonist and antagonist radioligands: the NMS/Oxo‐M ratio as an index of efficacy at cortical muscarinic receptorsBritish Journal of Pharmacology, 1988
- Pharmacological differences between two muscarinic responses of the rat superior cervical ganglion in vitroBritish Journal of Pharmacology, 1987
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982